✦ LIBER ✦

Is the reduced gradient following path a curve with extremal properties?

✍ Scribed by Bofill, Josep Maria

Book ID: 120310452
Publisher: American Institute of Physics
Year: 2009
Tongue: English
Weight: 339 KB
Volume: 130
Category: Article
ISSN: 0021-9606
DOI: 10.1063/1.3126266

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new look at the reduced-gradient-follo

A new look at the reduced-gradient-following path

✍ Ramon Crehuet; Josep Maria Bofill; Josep Maria Anglada 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 205 KB

Extremal properties of endochronic plast

Extremal properties of endochronic plasticity, part II: Extremal path of the constitutive equation with a yield surface and application

✍ Xianghe Peng; A.R.S. Ponter 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 644 KB

Extremal paths for endochronic constitutive equations without using a yield surface and the corresponding principle of minimum potential work were obtained in Part I of this article. In this paper, the extremal properties of endochronic constitutive equation with a yield surface and the correspondin

Percutaneous coronary intervention durin

Percutaneous coronary intervention during the index hospitalization is associated with reduced recurrent myocardial infarction and improved survival following thrombolytic administration

✍ C. Michael Gibson; Juhana Karha; Sabina A. Murphy; Christopher P. Cannon; Robert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Reduced mortality following bone marrow

Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver

✍ Fisher, D C; Vredenburgh, J J; Petros, W P; Hussein, A; Berry, D A; Elkordy, M; 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 61 KB

229: Twice-Daily Intravenous (IV) Busulf

229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults

✍ I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB